Clinical Trial Update: Anemia in Patients With a Non-Myeloid Malignancy [Phase 3]

View source ↗

Summary

Phase 3 trial update on anemia in patients with non-myeloid malignancies. The study sponsored by Amgen has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Cancer

Snippet

Sponsor: Amgen | Conditions: Neoplasms, Anemia | Phase 3 | Status: COMPLETED